SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.120+0.9%12:32 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: donpat who wrote (10329)5/24/2018 2:31:37 PM
From: HardToFind  Read Replies (1) of 12873
 
And that is exactly why penicillin took 20+ years to commercialise. But it was successful....eventually, though it took WW2 to get it there. I wonder what NNVC's cides will need?
To a futurist, that sounds pretty good. To a current investor...not so much.
It was difficult as hell! But they had the best minds on this planet working on it. JUST LIKE NNVC.
I don't think anybody is questioning the quality of the minds working on it. The medical community may still have full confidence in NNVC. Our current concern is the skill set...and Wall Street is where the goodwill has been lost.

We'll need some demonstrated progress and some luck in raising the money to continue operations.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News